7 institutions hold shares in Medigus Ltd. (MDGS), with 9.09k shares held by insiders accounting for 2.82% while institutional investors hold 11.26% of the company’s shares. The shares outstanding are 19.48M, and float is at 0.32M with Short Float at 27.10%. Institutions hold 10.94% of the Float.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The top institutional shareholder in the company is Citadel Advisors LLC with over 50611.0 shares valued at $69843.0. The investor’s holdings represent 0.25% of the MDGS Shares outstanding. As of Sep 29, 2020, the second largest holder is Wedbush Securities Inc with 14200.0 shares valued at $19596.0 to account for 0.07% of the shares outstanding.
Medigus Ltd. (NASDAQ: MDGS) is 67.02% higher on its value in year-to-date trading and has touched a low of $0.83 and a high of $5.15 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MDGS stock was last observed hovering at around $3.07 in the last trading session, with the day’s gains setting it 0.12% off its average median price target of $158.61 for the next 12 months. It is also 97.99% off the consensus price target high of $158.61 offered by 1 analysts, but current levels are 97.99% higher than the price target low of $158.61 for the same period.
Currently trading at $3.19, the stock is -0.55% and 25.83% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 8.72 million and changing 3.91% at the moment leaves the stock 51.11% off its SMA200. MDGS registered 95.73% gain for a year compared to 6-month gain of 114.09%. The firm has a 50-day simple moving average (SMA 50) of $2.8903 and a 200-day simple moving average (SMA200) of $2.1094.
The stock witnessed a 13.12% loss in the last 1 month and extending the period to 3 months gives it a 66.15%, and is -5.62% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.89% over the week and 11.85% over the month.
Medigus Ltd. (MDGS) has around 20 employees, a market worth around $62.15M and $0.20M in sales. Distance from 52-week low is 284.34% and -38.06% from its 52-week high.
Medigus Ltd. (MDGS) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Medigus Ltd. (MDGS) is a “Buy”. 1 analysts offering their recommendations for the stock, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Medigus Ltd. is expected to release its quarterly report on 06/02/2021..